EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS

作者Dilara Jappar; Jing Wu; Ute Burkard; Ashish Sharma; Carl Coeck; Donald Zoz; Yichao Yu

作者单位1. Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, USA; 2. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany; 3. Boehringer Ingelheim SComm, Brussels, Belgium

作者Asha K. Rajan; Vishal Shanbhag; Muhammed Rashid; Maria Ioana Onofrei; Indu Ramachandra Rao; Sohil A. Khan; Souvik Chaudhuri; Ravindra Prabhu Attur; Hassan Mitwally; Bhuvana Krishna; Vijayanarayana Kunhikatta; Surulivel Rajan; Girish Thunga

作者单位1. Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India; 2. Department of Critical Care Medicine, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India; 3. Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, USA; 4. Clinic of Infectious Diseases, “Sf.Parascheva” Clinical Hospital of Infectious Diseases, Lasi, Romania; 5. Department of Nephrology, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, India; 6. Pharmacotherapeutics and evidence-based practice, School of Pharmacy and Medical Sciences, Griffith University, Gold Coast, Australia; 7. Department of Pharmacy, Al Wakra Hospital, Hamad Medical Corporation, Doha, Ad Dawhah, Qatar; 8. Department of Critical Care Medicine, St John’s Medical College and Hospital, Bengaluru, India

作者Gabriel P. E. Silveira; Douglas P. Pinto; Luciana F. Portela; Sheila Suarez Fontes; Juliana Almeida-Silva; Alessandra L. Viçosa; Sandra Aurora C. Perez; Marcos André Vannier-Santos; Rita Estrela; Roberto M. Saraiva

作者单位1. Equivalence and Pharmacokinetics Service (Sefar), Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 2. Sérgio Arouca National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 3. Evandro Chagas Infectious Disease National Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 4. Innovations in Therapies, Education and Bioproducts Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 5. Experimental Pharmacotechnics Laboratory, Department of Galenic Innovation, Institute of Drug Technology - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 6. Project Management Technical Assistance, Institute of Drug Technology - Farmanguinhos, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil; 7. Pharmacometry Laboratory, Faculty of Pharmacy, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 8. Laboratory of Clinical Research on STD and AIDS, Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil

作者Paulina Stach; Kamil Skowron; Sebastian Rojek; Agnieszka Cios; Anna Wesołowska; Marilyn A. Huestis; Krzysztof Gil

作者单位1. Doctoral School of Medical and Health Sciences, Jagiellonian University-Collegium Medicum, Kraków, Poland; 2. Department of Pathophysiology, Faculty of Medicine, Medical College, Jagiellonian University, Kraków, Poland; 3. Department of Forensic Medicine, Faculty of Medicine, Medical College, Jagiellonian University, Kraków, Poland; 4. Department of Clinical Pharmacy, Faculty of Pharmacy, Medical College, Jagiellonian University, Kraków, Poland; 5. Institute of Emerging Health Professions, Thomas Jefferson University, Philadelphia, USA

作者Yaou Liu; Qingyu Yao; Xinhua Cui; Yimin Cui; Tianyan Zhou; Ran Xie; Xiaocong Pang

作者单位1. Department of Pharmacy, Peking University First Hospital, Beijing, China; 2. Drug Clinical Trial Institution, Beijing Key Laboratory of Clinical Pharmacology and Translation of Innovative Drugs, Peking University First Hospital, Beijing, China; 3. Institute of Clinical Pharmacology, Peking University, Beijing, China; 4. Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China

作者Derek Z. Yang; Kyle T. Matschke; Jennifer A. Winton; Kimberly C. Lee; Yuanyuan Zhang; Weiwei Tan

作者单位1. Pfizer Inc., San Diego, USA; 2. Pfizer, Inc., Collegeville, USA; 3. Pfizer, Inc., Groton, USA; 4. Arvinas Operations, Inc., New Haven, USA

作者Chin Chiang Toh; Mohd Makmor Bakry; Noraida Mohamed Shah; Shamin Mohd Saffian

作者单位1. Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; 2. Department of Pharmacy, Tunku Azizah Hospital, Ministry of Health Malaysia, Kuala Lumpur, Malaysia

作者Mrunal Pradeep Desai; Prajakta Harish Patil; Anithakumari Uttam Singh Rajpurohit; Vullendula Sai Krishna Anand; Jagadish Puralae Channabasavaiah

作者单位1. Department of Pharmaceutical Chemistry, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India; 2. Department of Pharmaceutical Quality Assurance, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal, India

作者Alexandra Villalpando-Solórzano; Ashley Marieth Ramirez-Díaz; José Giovanni Navarro-Rangel; Yair Lara-Blanco; Genaro Rodríguez-Uribe; José Román Chavez-Méndez

作者单位1. Faculty of Health Sciences Valle de las Palmas, Universidad Autónoma de Baja California, Tijuana, Mexico; 2. Faculty of Medicine and Psychology, Universidad Autónoma de Baja California, Tijuana, Mexico

作者Tuan Fauziah; Ganesh Kasinathan; Teng Keat Chew; Mohd Makmor-Bakry; Yi Lin Lee; Noraida Mohamed Shah; Shamin Mohd Saffian

作者单位1. Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia; 2. Hematology Department Hospital Ampang, Ministry of Health Malaysia, Selangor, Malaysia; 3. Hematology Department Hospital Pulau Pinang, Ministry of Health Malaysia, Pulau Pinang, Malaysia; 4. Clinical Research Center Hospital Ampang, Ministry of Health Malaysia, Selangor, Malaysia